Tiverton Asset Management’s Agios Pharmaceuticals AGIO Stock Holding History

Tiverton Asset Management’s Portfolio AGIO Stock Details AGIO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	$168K	Buy	5,197 +3,499	+206%	+$145K	0.01%	577
2019 Q2	$85K	Sell	1,698 -21,351	-93%	-$1.14M	﹤0.01%	636
2019 Q1	$1.55M	Buy	23,049 +6,991	+44%	+$407K	0.07%	189
2018 Q4	$741K	Buy	+16,058	New	+$991K	0.04%	202
2018 Q3	–	Sell	-1,681	Closed	-$142K	–	411
2018 Q2	$142K	Buy	+1,681	New	+$147K	0.01%	350

Other funds holding AGIO

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Tiverton Asset Management's AGIO Position: Q3 2019 in Review

Tiverton Asset Management increased its Agios Pharmaceuticals (AGIO) stake by 206% in Q3 2019, buying an estimated $145K and bringing the position to 5,197 shares worth $168K. The position accounts for 0.01% of the portfolio, ranked #577.

Tiverton Asset Management first reported a position in AGIO in Q2 2018 and has held it in 5 quarters since. The position peaked at $1.55M in Q1 2019. 189 funds tracked by Wall St. Rank hold AGIO as of Q3 2019.

Tiverton Asset Management held 5,197 shares of Agios Pharmaceuticals worth $168K as of Q3 2019.
Tiverton Asset Management bought 3,499 Agios Pharmaceuticals shares in Q3 2019, an estimated $145K.
Agios Pharmaceuticals made up 0.01% of Tiverton Asset Management's portfolio in Q3 2019, its #577 holding.
Tiverton Asset Management first reported a position in Agios Pharmaceuticals in Q2 2018 and has held it in 5 quarters since.
Tiverton Asset Management's Agios Pharmaceuticals position peaked at $1.55M in Q1 2019.
189 funds tracked by Wall St. Rank held Agios Pharmaceuticals as of Q3 2019.

Based on Tiverton Asset Management's 13F filing for Q3 2019, filed 13 Nov 2019.